PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50122C00047 — CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL

CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL is a federal NONE award for Department of Health and Human Services (HHS) held by CHIMERIX, INC.. Estimated value $213.8M ($213.8M obligated). Current period of performance ends Oct 1, 2028 (potential Aug 28, 2032). Last award drew 1 bidder. Place of performance: DURHAM, NC. Related solicitation 75A50122R00012.

$213.8M
Estimated Value
Oct 1, 2028
PoP End / Expires
1
Bidders (last award)

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

See related expiring contracts →

Analysis

Public

CHIMERIX, INC. holds $-614,221 across 1 federal awards. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Oct 1, 2028 PoP end — agencies typically plan 12–18 months ahead.

Contract facts

NONE
Contract number75A50122C00047
AgencyDepartment of Health and Human Services (HHS)
IncumbentCHIMERIX, INC.
UEIKLDQF5TYQM45
NAICS541714

No full NAICS 541714 intel page yet. Browse NAICS intelligence

PSCAJ15
Place of performanceDURHAM, NC
Related solicitation75A50122R00012
PoP end (current)Oct 1, 2028
PoP end (w/ options)Aug 28, 2032
Obligated$213.8M

CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL

Recompete timing

Public
Expiring in 777 days

Current PoP ends Oct 1, 2028 (777 days remaining). Agencies typically plan 12–18 months ahead — capture window opens around Apr 1, 2027.

Watch this contract — one email →

Incumbent footprint

Public record

CHIMERIX, INC.$-614,221 obligated across 1 awards (firm-wide, all agencies).

Open full company profile

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP

Track this contract

Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

More in SCOUT
Track this contract →

Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.

Size up the competition →

See all live recompete landscapes — who else is expiring, and where the openings are.

Research the incumbent →

Open CHIMERIX, INC.’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.

Frequently asked questions

What is contract 75A50122C00047?

75A50122C00047 (CHIMERIX INC: AR&D FOR SMALLPOX ANTIVIRAL) is a Department of Health and Human Services (HHS) award with an estimated value of $213.8M, currently held by CHIMERIX, INC.. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.

Who is the incumbent on 75A50122C00047?

CHIMERIX, INC. is the incumbent with $-614,221 across 1 related awards in SCOUT’s public footprint. The current period of performance ends Oct 1, 2028.

When does 75A50122C00047 come up for recompete?

SCOUT tracks a period-of-performance end of Oct 1, 2028. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50122C00047